Karyotyping - Blood (Wife)
Genetic0 parametersReport in 720HrsAt Home
No Fasting Required
Details
Used in the diagnosis of genetic diseases, infertility, recurrent miscarriages, birth defects, and hematologic malignancies
₹2,499₹4,400
43% OFF
FREE:AI InsightsHome pickup
Karyotyping - Blood (Wife)
- Why is it done?
- Evaluates the complete set of chromosomes to detect numerical and structural abnormalities that may affect fertility or pregnancy outcomes
- Identifies chromosomal disorders such as trisomies (Down syndrome, Edwards syndrome, Patau syndrome) and monosomies that may cause recurrent miscarriages or infertility
- Detects structural rearrangements such as balanced translocations, inversions, or deletions that may impact reproductive success
- Ordered as part of infertility workup, particularly in cases of recurrent miscarriage or unexplained infertility
- Recommended prior to assisted reproductive techniques (ART) or in vitro fertilization (IVF) to assess reproductive potential
- May be performed when family history suggests chromosomal abnormalities or genetic disorders
- Normal Range
- Normal Karyotype: 46,XX (46 chromosomes with two X chromosomes in females)
- Unit of Measurement: Chromosomal notation (number and morphology)
- Normal Result Interpretation: No chromosomal abnormalities detected; all 46 chromosomes present with normal structure and number
- Abnormal Result Interpretation: Presence of extra, missing, or rearranged chromosomes indicating genetic disorder or carrier status
- Borderline/Mosaic Results: May indicate presence of two or more cell lines with different karyotypes, requiring further investigation
- Interpretation
- Normal Results (46,XX): No chromosomal abnormalities present; normal female karyotype with normal reproductive potential
- Trisomy Results (e.g., 47,XX,+21): Extra chromosome detected; may indicate Down syndrome if present in all cells or contribute to recurrent miscarriage
- Monosomy Results (e.g., 45,X): Missing chromosome detected; Turner syndrome or variants that may cause infertility or pregnancy complications
- Balanced Translocation (e.g., 46,XX,der(13;14)(q10;q10)): Chromosomal material rearranged but no genetic material lost; carrier status with increased risk of unbalanced offspring or miscarriage
- Inversion Results (e.g., 46,XX,inv(9)): Segment of chromosome reversed; may have reduced fertility or increased miscarriage risk depending on type and size
- Deletion Results (e.g., 46,XX,del(5p)): Missing chromosomal segment; may cause reproductive failure, congenital abnormalities, or developmental disorders
- Mosaic Karyotype (e.g., 46,XX/47,XX,+21): Different cell populations with different chromosome numbers; may indicate mosaicism with variable clinical expression
- Factors Affecting Results:
- Cell culture quality and ability to obtain adequate metaphase cells
- Band resolution (banding technique used may affect detection of small abnormalities)
- Presence of mosaicism affecting detection sensitivity
- Sample quality and timing of processing
- Associated Organs
- Primary Systems Affected:
- Reproductive system (ovaries, fallopian tubes, uterus) - affecting fertility and pregnancy outcomes
- All body systems (chromosomal abnormalities affect entire organism)
- Associated Medical Conditions:
- Down syndrome (Trisomy 21) - intellectual disability, congenital heart disease, recurrent miscarriages
- Edwards syndrome (Trisomy 18) - severe developmental abnormalities, often lethal in utero or shortly after birth
- Patau syndrome (Trisomy 13) - severe intellectual and physical abnormalities, high rate of miscarriage
- Turner syndrome (45,X or variants) - infertility, short stature, cardiac abnormalities, webbed neck
- Balanced translocation carrier status - increased risk of recurrent miscarriage and chromosomally unbalanced offspring
- Recurrent pregnancy loss/miscarriage - may be due to chromosomal abnormalities in one partner
- Infertility (primary or secondary) - chromosomal abnormalities may impair fertility
- Potential Complications with Abnormal Results:
- Reduced fertility and difficulty conceiving naturally
- Increased risk of chromosomally abnormal embryos and miscarriage
- Birth of child with genetic disorder requiring lifelong medical management
- Need for advanced reproductive techniques such as preimplantation genetic diagnosis (PGD)
- Psychological impact of carrier status and reproductive counseling needs
- Follow-up Tests
- If Normal Results:
- Hormonal assessment (FSH, LH, prolactin, thyroid function) if infertility is the primary concern
- Pelvic ultrasound to assess reproductive anatomy
- Semen analysis and male partner karyotyping if not previously performed
- Proceed with fertility treatment if appropriate (IVF, IUI, or other assisted reproductive techniques)
- If Abnormal Results Detected:
- Fluorescence in situ hybridization (FISH) - for confirmation of specific chromosomal abnormalities
- Chromosomal microarray (array CGH) - to detect submicroscopic deletions/duplications
- Genetic counseling - to understand implications and reproductive options
- Parental karyotyping - to determine if abnormality is inherited or de novo
- Preimplantation genetic diagnosis (PGD) - if pursuing IVF with genetic screening
- Prenatal testing options - noninvasive prenatal testing (NIPT), amniocentesis, or chorionic villus sampling (CVS) for future pregnancies
- Complementary/Related Tests:
- Partner/spouse karyotyping - essential for counseling and reproductive decision-making
- Fetal karyotyping - if abnormality detected and pregnancy established
- Fragile X testing - if intellectual disability or developmental delay suspected
- Carrier screening for other genetic disorders as appropriate
- Monitoring Frequency:
- One-time test typically performed; repeat testing not usually necessary unless sample quality was inadequate
- Ongoing genetic counseling recommended for carriers of structural abnormalities prior to conception
- Periodic reassessment as reproductive plans change
- Fasting Required?
- Fasting Required: No
- Patient Preparation:
- No special dietary restrictions required
- Regular meals and hydration are permissible and recommended
- Medications may be continued normally; inform laboratory of all current medications and supplements
- No special timing requirements; test can be performed at any time of day
- Some laboratories prefer samples collected in morning; check with specific laboratory for preferences
- Sample Collection:
- Peripheral blood sample collected via venipuncture into sterile tube with culture medium (typically EDTA or sodium heparin tube)
- No significant discomfort associated with sample collection
- Sample processing typically requires 7-14 days for cell culture and analysis
- Contraindications or Cautions:
- Recent blood transfusion or organ transplant may affect results; inform laboratory if applicable
- Active infection or fever may require test postponement; consult with physician
- No other special precautions or restrictions needed
How our test process works!
